Dealing in Securities by Directors
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")
DEALING IN SECURITIES BY DIRECTORS
In compliance with paragraph 3.63 of the Listings Requirements of the
JSE Limited, disclosure is made of the following information:
Deferred bonus shares, awarded in 2015 in respect of the Aspen South
African Management Deferred Incentive Scheme, have vested and have been
accepted by the undermentioned directors of the Company.
BY DIRECTORS OF THE COMPANY:
Director : Michael Guy Attridge
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 6 November 2018
Shares delivered – off market : 7 798
Price : R 163.01
Value of shares delivered : R 1 271 151.98
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
BY DIRECTORS OF THE COMPANY:
Director : Stephen Bradley Saad
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 6 November 2018
Shares delivered – off market : 9 576
Price : R 163.01
Value of shares delivered : R 1 560 893.76
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
Durban
7 November 2018
Sponsor
Investec Bank Limited
Date: 07/11/2018 05:45:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.